ID Biomedical Seeking FluINsure Development Partner For U.S. Market
Executive Summary
ID Biomedical is seeking a development partner for securing U.S. approval of its inactived intranasal flu vaccine FluINsure, President Todd Patrick said
You may also be interested in...
ID Biomedical Opens Channel For Fluviral Distribution in U.S.
Henry Schein has committed to purchasing approximately half of all ID Biomedical Fluviral doses produced for the U.S. under a distribution agreement for the flu vaccine unveiled by the companies Dec. 6
ID Biomedical Opens Channel For Fluviral Distribution in U.S.
Henry Schein has committed to purchasing approximately half of all ID Biomedical Fluviral doses produced for the U.S. under a distribution agreement for the flu vaccine unveiled by the companies Dec. 6
FDA To Determine Flu Vaccine Suppliers For 2005-2006 Season In January
FDA will decide whether Chiron can produce flu vaccine for next season by Jan. 5, Acting Commissioner Lester Crawford, PhD, said Nov. 18